DNMT3A and mixed phenotype acute leukemia: Mutations in PHF6 and DNMT3A are mutually exclusive in MPAL, correlate with T-lineage marker expression (83% and 100%, respectively), and have higher relapse at 2 years (58% and 79%, respectively) compared to MPAL lacking these mutations (70).